Typical and atypical bronchopulmonary carcinoid tumors on FDG PET/CT imaging

被引:33
作者
Wartski, M
Alberini, JL
Leroy-Ladurie, F
De Montpreville, V
Nguyen, C
Corone, C
Dartevelle, P
Pecking, AP
机构
[1] Canc Res Ctr Rene Huguenin, Dept Nucl Med, F-92210 St Cloud, France
[2] Surg Ctr Marie Lannelongue, Le Plessis Robinson, France
关键词
bronchial carcinoid tumors; FDG; fluorodeoxyglucose; positron emission tomography; endocrine tumors; lung cancer;
D O I
10.1097/00003072-200411000-00026
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The authors report 2 cases of bronchial carcinoid tumor (BCT). One had a typical and the other had an atypical histologic pattern. BCTs represent 1 to 2% of all lung cancers and are usually located in the hilar or perihilar areas. They can be associated with infectious processes. Typical carcinoids are considered as having low-grade malignancy although atypical carcinoids are of intermediate grade. The authors showed that even a typical carcinoid can show intense F-18 FDG uptake. The number of reports of BCT in PET imaging using FDG in BCT is very limited, but several cases of FDG-negative BCT have been described.
引用
收藏
页码:752 / 753
页数:2
相关论文
共 9 条
[1]   Positron emission tomography imaging in nonmalignant thoracic disorders [J].
Alavi, A ;
Gupta, N ;
Alberini, JL ;
Hickeson, M ;
Adam, LE ;
Bhargava, P ;
Zhuang, HM .
SEMINARS IN NUCLEAR MEDICINE, 2002, 32 (04) :293-321
[2]   Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67 [J].
Belhocine, T ;
Foidart, J ;
Rigo, P ;
Najjar, F ;
Thiry, A ;
Quatresooz, P ;
Hustinx, R .
NUCLEAR MEDICINE COMMUNICATIONS, 2002, 23 (08) :727-734
[3]   Evaluation of primary pulmonary carcinoid tumors using FDG PET [J].
Erasmus, JJ ;
McAdams, HP ;
Patz, EF ;
Coleman, RE ;
Ahuja, V ;
Goodman, PC .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1998, 170 (05) :1369-1373
[4]   Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis -: A postitron emission tomography study [J].
Hara, T ;
Kosaka, N ;
Suzuki, T ;
Kudo, K ;
Niino, H .
CHEST, 2003, 124 (03) :893-901
[5]  
REGE SD, 1993, CANCER-AM CANCER SOC, V72, P82, DOI 10.1002/1097-0142(19930701)72:1<82::AID-CNCR2820720117>3.0.CO
[6]  
2-3
[7]   Clinical-radiological presentation and outcome of surgically treated pulmonary carcinoid tumours: a long-term single institution experience [J].
Schrevens, L ;
Vansteenkiste, J ;
Deneffe, G ;
De Leyn, P ;
Verbeken, E ;
Vandenberghe, T ;
Demedts, M .
LUNG CANCER, 2004, 43 (01) :39-45
[8]   Pulmonary neuroendocrine tumors: Incidence and prognosis of histological subtypes. A population-based study in Denmark [J].
Skuladottir, H ;
Hirsch, FR ;
Hansen, HH ;
Olsen, JH .
LUNG CANCER, 2002, 37 (02) :127-135
[9]   Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid [J].
Travis, WD ;
Rush, W ;
Flieder, DB ;
Falk, R ;
Fleming, MV ;
Gal, AA ;
Koss, MN .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (08) :934-944